Director Gérard Ber to resign from Y-mAbs board effective June 10, 2024

Y-mAbs Therapeutics, Inc.

Gérard Ber, Ph.D., notified Y-mAbs that he will resign from the Board of Directors, effective June 10, 2024.
Resignation is not due to any disagreement with the Company regarding operations, policies, or practices.
Dr. Ber will remain available for consultation and advice following his resignation.
The Company thanked Dr. Ber for his commitment and service.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gérard Ber

Director

Y-mAbs Therapeutics, Inc.

Effective: 2024-06-10
Filed: April 29, 2024, 7:59 PM ET

On April 25, 2024, Gérard Ber, Ph.D., notified Y-mAbs Therapeutics, Inc. (the “Company”) that he would be resigning from the Board of Directors of the Company, with such resignation to be effective on June 10, 2024, the day before the date set for the Company’s 2024 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gérard Ber resigned as Director at Y-mAbs Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On April 25, 2024, Gérard Ber, Ph.D., notified Y-mAbs Therapeutics, Inc. (the “Company”) that he would be resigning from the Board of Directors of the Company, with such resignation to be effective on June 10, 2024, the day before the date set for the Company’s 2024 annual meeting of stockholders.

View on SEC.gov

Source: SEC EDGAR

accession 0001104659-24-054165

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.